Bisson Jonathan I, Roberts Neil P, Andrew Martin, Cooper Rosalind, Lewis Catrin
Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cardiff, UK, CF24 4HQ.
Cochrane Database Syst Rev. 2013 Dec 13;2013(12):CD003388. doi: 10.1002/14651858.CD003388.pub4.
Post-traumatic stress disorder (PTSD) is a distressing condition, which is often treated with psychological therapies. Earlier versions of this review, and other meta-analyses, have found these to be effective, with trauma-focused treatments being more effective than non-trauma-focused treatments. This is an update of a Cochrane review first published in 2005 and updated in 2007.
To assess the effects of psychological therapies for the treatment of adults with chronic post-traumatic stress disorder (PTSD).
For this update, we searched the Cochrane Depression, Anxiety and Neurosis Group's Specialised Register (CCDANCTR-Studies and CCDANCTR-References) all years to 12th April 2013. This register contains relevant randomised controlled trials from: The Cochrane Library (all years), MEDLINE (1950 to date), EMBASE (1974 to date), and PsycINFO (1967 to date). In addition, we handsearched the Journal of Traumatic Stress, contacted experts in the field, searched bibliographies of included studies, and performed citation searches of identified articles.
Randomised controlled trials of individual trauma-focused cognitive behavioural therapy (TFCBT), eye movement desensitisation and reprocessing (EMDR), non-trauma-focused CBT (non-TFCBT), other therapies (supportive therapy, non-directive counselling, psychodynamic therapy and present-centred therapy), group TFCBT, or group non-TFCBT, compared to one another or to a waitlist or usual care group for the treatment of chronic PTSD. The primary outcome measure was the severity of clinician-rated traumatic-stress symptoms.
We extracted data and entered them into Review Manager 5 software. We contacted authors to obtain missing data. Two review authors independently performed 'Risk of bias' assessments. We pooled the data where appropriate, and analysed for summary effects.
We include 70 studies involving a total of 4761 participants in the review. The first primary outcome for this review was reduction in the severity of PTSD symptoms, using a standardised measure rated by a clinician. For this outcome, individual TFCBT and EMDR were more effective than waitlist/usual care (standardised mean difference (SMD) -1.62; 95% CI -2.03 to -1.21; 28 studies; n = 1256 and SMD -1.17; 95% CI -2.04 to -0.30; 6 studies; n = 183 respectively). There was no statistically significant difference between individual TFCBT, EMDR and Stress Management (SM) immediately post-treatment although there was some evidence that individual TFCBT and EMDR were superior to non-TFCBT at follow-up, and that individual TFCBT, EMDR and non-TFCBT were more effective than other therapies. Non-TFCBT was more effective than waitlist/usual care and other therapies. Other therapies were superior to waitlist/usual care control as was group TFCBT. There was some evidence of greater drop-out (the second primary outcome for this review) in active treatment groups. Many of the studies were rated as being at 'high' or 'unclear' risk of bias in multiple domains, and there was considerable unexplained heterogeneity; in addition, we assessed the quality of the evidence for each comparison as very low. As such, the findings of this review should be interpreted with caution.
AUTHORS' CONCLUSIONS: The evidence for each of the comparisons made in this review was assessed as very low quality. This evidence showed that individual TFCBT and EMDR did better than waitlist/usual care in reducing clinician-assessed PTSD symptoms. There was evidence that individual TFCBT, EMDR and non-TFCBT are equally effective immediately post-treatment in the treatment of PTSD. There was some evidence that TFCBT and EMDR are superior to non-TFCBT between one to four months following treatment, and also that individual TFCBT, EMDR and non-TFCBT are more effective than other therapies. There was evidence of greater drop-out in active treatment groups. Although a substantial number of studies were included in the review, the conclusions are compromised by methodological issues evident in some. Sample sizes were small, and it is apparent that many of the studies were underpowered. There were limited follow-up data, which compromises conclusions regarding the long-term effects of psychological treatment.
创伤后应激障碍(PTSD)是一种令人痛苦的疾病,通常采用心理疗法进行治疗。本综述的早期版本以及其他荟萃分析均发现这些疗法是有效的,其中以创伤为重点的治疗比不以创伤为重点的治疗更有效。这是Cochrane综述的更新版本,该综述首次发表于2005年,并于2007年进行了更新。
评估心理疗法对治疗成年慢性创伤后应激障碍(PTSD)的效果。
对于本次更新,我们检索了Cochrane抑郁、焦虑和神经症小组的专业注册库(CCDANCTR-研究和CCDANCTR-参考文献)至2013年4月12日的所有年份数据。该注册库包含来自以下资源的相关随机对照试验:Cochrane图书馆(所有年份)、MEDLINE(1950年至今)、EMBASE(1974年至今)和PsycINFO(1967年至今)。此外,我们还手工检索了《创伤应激杂志》,联系了该领域的专家,检索了纳入研究的参考文献,并对已识别文章进行了引文检索。
针对个体以创伤为重点的认知行为疗法(TFCBT)、眼动脱敏再处理疗法(EMDR)、不以创伤为重点的认知行为疗法(非TFCBT)、其他疗法(支持性疗法、非指导性咨询、心理动力疗法和以当下为中心的疗法)、团体TFCBT或团体非TFCBT的随机对照试验,这些试验相互比较,或与等待名单或常规护理组比较,用于治疗慢性PTSD。主要结局指标是临床医生评定的创伤应激症状的严重程度。
我们提取数据并将其录入Review Manager 5软件。我们联系作者以获取缺失数据。两位综述作者独立进行“偏倚风险”评估。我们在适当情况下合并数据,并分析汇总效应。
我们纳入了70项研究,共涉及4761名参与者。本综述的第一个主要结局是使用临床医生评定的标准化量表来降低PTSD症状的严重程度。对于该结局,个体TFCBT和EMDR比等待名单/常规护理更有效(标准化均数差(SMD)-1.62;95%置信区间-2.03至-1.21;28项研究;n = 1256,以及SMD -1.17;95%置信区间-2.04至-0.30;6项研究;n = 183)。治疗后即刻,个体TFCBT、EMDR与应激管理(SM)之间无统计学显著差异,尽管有一些证据表明个体TFCBT和EMDR在随访时优于非TFCBT,且个体TFCBT、EMDR和非TFCBT比其他疗法更有效。非TFCBT比等待名单/常规护理和其他疗法更有效。其他疗法优于等待名单/常规护理对照组,团体TFCBT也是如此。有一些证据表明在积极治疗组中有更高的脱落率(本综述的第二个主要结局)。许多研究在多个领域被评定为具有“高”或“不清楚”的偏倚风险,并且存在相当多无法解释的异质性;此外,我们将每个比较的证据质量评估为非常低。因此,本综述的结果应谨慎解读。
本综述中所做的每个比较的证据质量被评估为非常低。该证据表明,个体TFCBT和EMDR在降低临床医生评定的PTSD症状方面比等待名单/常规护理表现更好。有证据表明,个体TFCBT、EMDR和非TFCBT在治疗PTSD后即刻同样有效。有一些证据表明,TFCBT和EMDR在治疗后1至4个月比非TFCBT更优,并且个体TFCBT、EMDR和非TFCBT比其他疗法更有效。有证据表明在积极治疗组中有更高的脱落率。尽管本综述纳入了大量研究,但结论受到一些明显方法学问题的影响。样本量较小,并且很明显许多研究的效能不足。随访数据有限,这影响了关于心理治疗长期效果的结论。